Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

BACKGROUND: We studied the comparative effectiveness of biosimilar filgrastim vs original filgrastim in patients with chemotherapy-induced neutropenia. PATIENTS AND METHODS: This multicenter, observational study was conducted at 14 centers. The study included 337 patients experiencing neutropenia un...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Onco Targets Ther
Glavni autori: Sevinç, Alper, Özkan, Metin, Özet, Ahmet, Dane, Faysal, Öksüzoğlu, Berna, Işıkdoğan, Abdurrahman, Özdemir, Feyyaz, Uncu, Doğan, Gümüş, Mahmut, Evrensel, Türkkan, Yaren, Arzu, Kara, Oğuz, Tekin, Salim Başol
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5783019/
https://ncbi.nlm.nih.gov/pubmed/29403286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S106342
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items